None of the 175 recruitedpatients dropped out of the study. ResultsEach group of 35 patients randomlyreceived one of the following IOLs:AcrySof1 MA30BA (Alcon) Sensar1ĪR40 (AMO) AcrySof1 SA30AL(Alcon) Sensar1 AR40e (AMO), orTecnis1 Z9000 (Pharmacia & UpjohnCo.). Non-significant p-valuesbetween 0.05 and 0.1 were also reported.All statistical analyses were per. With respect to difficultyin driving at night, the MA30BA group had a significant higher incidence ofphotic phenomena than the SA30AL, AR40e and Z9000 groups (p 95%, were consideredsignificant. Two months postoperatively, we collected dataregarding subjective glare and evaluated pupil size, visual acuity and wavefrontaberration of the cornea and eye.Results: With regard to difficulty in performing ordinary activities under differ-ent light conditions and light and dark adaptation, the difference between thegroups was not significant (p > 0.05, chi-squared test). All patients received a questionnaire investigating the incidence ofsubjective photic phenomena. SA30AL, Alcon Sensar1 AR40e, AMO, and Tecnis1 Z9000, Pharmacia &Upjohn). Italy2Department of Surgery and Bioengineering, University of Siena, Siena, ItalyĪBSTRACT.Purpose: To compare differences in subjective glare and spherical aberrationbetween five foldable intraocular lenses (IOLs) made of different materials andto different designs.Methods: This prospective study comprised 175 cataract patients who under-went phacoemulsification and were randomized to receive one of five types offoldable IOL (AcrySof1 MA30BA, Alcon Sensar1 AR40, AMO AcrySof1 Miracco,1 Gianluca Martone,1 Gabriele Cevenini2 and AldoġDepartment of Ophthalmology and Neurosurgery, University of Siena, Siena, 125000001424 substituent group Chemical group 0.Glare disability and sphericalaberration with five foldableintraocular lenses: a prospectiverandomized studyFabrizio Casprini,1 Angelo Balestrazzi,1 Gian Marco Tosi,1 Flavia.239000011796 hollow space material Substances 0.000 claims abstract description 14.238000006460 hydrolysis reaction Methods 0.000 claims abstract description 20.230000002708 enhancing Effects 0.000 claims abstract description 74.238000003780 insertion Methods 0.000 title claims abstract description 32.Status Active legal-status Critical Current Anticipated expiration legal-status Critical Links CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). reassignment Johnson & Johnson Surgical Vision, Inc. I PP2017OTH0867 ESRIPIN AR ARE ARe CARAERSIC AS PIC AS Potencias: -10.0 D a +1.5 D con incrementos de 0.5 dioptras +2.0 D a +5.5 D con incrementos de 0.5 dioptras +6.0 a +30.0 D con. Application granted granted Critical Publication of US9421091B2 publication Critical patent/US9421091B2/en Assigned to Johnson & Johnson Surgical Vision, Inc. OptiEdge, Sensar y UNFOLDER son marcas propiedad o bajo licencia de Abbott Medical Optics Inc., sus subsidiarias y afiliadas. Assignors: MAKKER, HARISH, HU, CAN B., LOWERY, MICHAEL D. AND e-ri I I N Q AR40E IN FDU RIOH BAAB-I OWNER MUST SELL rnom f. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). of the reel kM >t our local election campelgn as they unfold from dey to day. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Priority to US10/608,875 priority Critical patent/US20040267359A1/en Priority to US11/146,983 priority patent/US7687097B2/en Priority to US12/622,554 priority patent/US8956684B2/en Application filed by Abbott Medical Optics Inc filed Critical Abbott Medical Optics Inc Priority to US14/623,347 priority patent/US9421091B2/en Publication of US20150157454A1 publication Critical patent/US20150157454A1/en Assigned to Abbott Medical Optics Inc. Original Assignee Abbott Medical Optics Inc Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.) Lowery Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.) Active Application number US14/623,347 Other versions US20150157454A1 Google Patents US9421091B2 - IOL insertion apparatusĭownload PDF Info Publication number US9421091B2 US9421091B2 US14/623,347 US201514623347A US9421091B2 US 9421091 B2 US9421091 B2 US 9421091B2 US 201514623347 A US201514623347 A US 201514623347A US 9421091 B2 US9421091 B2 US 9421091B2 Authority US United States Prior art keywords component intraocular lens insertion system lens insertion lubricity enhancing Prior art date Legal status (The legal status is an assumption and is not a legal conclusion.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |